Page Image

The HemOnc Pulse

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Chadi Nabhan, MD, MBA, FACP, covering all topics in the world of hematologic oncology.

Chadi Nabhan, MD, MBA, FACPAggressive B-Cell Lymphoma | September 14, 2023
Jonathan Friedberg, MD, MMSc, discusses the trial and its implications for the field.
Listen Now
Chadi Nabhan, MD, MBA, FACPMeeting News | September 13, 2023
Dr. Garcia-Manero discusses key data from the phase III COMMANDS trial.
Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | August 24, 2023
Dr. Shadman rounds up the latest news on CLL from the summer conferences in this episode of The HemOnc Pulse.
Chadi Nabhan, MD, MBA, FACPAcute Myeloid Leukemia | August 10, 2023
The changes brought about by molecular characterization have a profound impact on real-world clinical care for AML.
Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | July 27, 2023
Nitin Jain, MD, discusses the data on venetoclax combinations in CLL and key frontline treatment considerations.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | July 13, 2023
Dr. Nowakowski discusses the L-MIND study and the "revolution in the treatment of DLBCL" in recent years.
Chadi Nabhan, MD, MBA, FACPAcute Myeloid Leukemia | June 29, 2023
Naveen Pemmaraju, MD, discusses the rare, ultrarare, and forgotten blood cancers on this episode of The HemOnc Pulse.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | June 15, 2023
Dr. Majhail explores strategies to improve access to CAR-T therapy.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | May 18, 2023
Drs. Vijenthira and Prica discuss their study and why its results differed from a similar study published in late 2022.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | May 4, 2023
Sagar Lonial, MD, FACP, discusses how he approaches frontline therapy for multiple myeloma and key MRD considerations.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | April 20, 2023
Alan Skarbnik, MD, of Novant Health, discusses treating patients with follicular lymphoma and the nuances involved.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | April 6, 2023
Amer Zeidan, MBBS, MHS, of Yale, discusses the impact of AML classification updates and treatment considerations.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | March 23, 2023
Drs. Kambhampati and Thiruvengadam discuss their study investigating the cost effectiveness of pola-R-CHP in DLBCL.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | March 9, 2023
Graham Collins, MD, discusses how to navigate the latest research in Hodgkin lymphoma.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | February 23, 2023
Dr. Bishop discusses the matter with host Chadi Nabhan, MD, MBA, FACP, and speaks about why CAR-T doesn't always work.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | February 9, 2023
Dr. Sehn also explains why the TRIANGLE study is anticipated to change practices surrounding transplant in MCL.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | January 26, 2023
Sanam Loghavi, MD, chats with The HemOnc Pulse host Chadi Nabhan, MD, MBA, FACP, about why 2022 was a major year for MDS.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | January 12, 2023
In this episode, Chadi Nabhan, MD, MBA, FACP, talks with Elizabeth Brem, MD, about CLL highlights from ASH 2022.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | December 29, 2022
Ruben Mesa, MD, discusses his career in MPN treatment and research and notable abstracts at the 2022 ASH Annual Meeting.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | December 14, 2022
In the inaugural episode of The HemOnc Pulse, Chadi Nabhan, MD, MBA, FACP, hosts Hagop Kantarjian, MD, and Elias Jabbour, MD.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | November 21, 2022
Blood Cancers Today announces the launch of The HemOnc Pulse, a new podcast hosted by Chadi Nabhan, MD, MBA, FACP.
Advertisement
Advertisement
Advertisement
Advertisement